In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Among older adults and adults with low ASCVD risk for whom aspirin is not recommended, use of aspirin decreased after 2019 changes in guideline recommendations.

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...

The U.S. Preventive Services Task Force issued new recommendations advising people age 60 and older to not begin taking ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American ...

Expert Rev Cardiovasc Ther. 2012;10(4):433-439. This article suggests the need to reconsider the benefits of using aspirin in stroke prevention, especially in low-risk patients or patients not ...

Study of 107,000 participants demonstrates regular aspirin use significantly reduces colorectal cancer risk, especially in individuals with unhealthy lifestyles ...